R&D

Piramal Group has interests in a portfolio of businesses including financial services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited), and real estate (Piramal Realty). With operations in 30 countries and brand presence in over 100 markets, the Group’s turnover is ~1.9 billion usd in FY 2022. Driven by its core values, the Group pursues inclusive growth, while adhering to ethical and value-driven practices.

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

Walk in Interviews for Formulation R&D

The Vallabhbhai Patel Chest Institute (VPCI) is a unique postgraduate medical institution devoted to research, teaching and patient care in the field of chest diseases. It is a University of Delhi maintained institution and is funded entirely by the Ministry of Health and Family Welfare, Government of India. The Institute is ideally located in the heart of the main campus of the University of Delhi, providing the requisite academic environment.

The AIIMS, New Delhi model will be adopted and adapted. Unlike the Postgraduate Institutes which lack the basic departments like Anatomy, Physiology, Pharmacology, General Medicine, Surgery, Obstetrics & Gynaecology etc, the new AIIMS will have these departments as well as the superspecialty departments like neurosurgery, cardiac surgery, urology, endocrinology etc.

The AIIMS, New Delhi model will be adopted and adapted. Unlike the Postgraduate Institutes which lack the basic departments like Anatomy, Physiology, Pharmacology, General Medicine, Surgery, Obstetrics & Gynaecology etc, the new AIIMS will have these departments as well as the superspecialty departments like neurosurgery, cardiac surgery, urology, endocrinology etc.

Post : Senior Research Fellow (1 Position)

In 1978, Centaur Pharmaceuticals, commenced pharmaceutical manufacturing operations in Mumbai and has now evolved into a vertically integrated pharmaceutical company. Centaur House, our corporate headquarters, is located in Mumbai, the commercial capital of India. Centaur has a strong matrix of capabilities across the pharmaceutical value chain including API, formulations, Contract Research and Manufacturing Services, Clinical Research, R&D, regulatory and marketing.

National Agri-Food Biotechnology Institute (NABI) is an autonomous Institute under the Department of Biotechnology, Government of India. NABI aims at catalyzing the transformation of the Agri-food sector in India by being a nodal organization for knowledge generation and translational science leading to value-added products based on Agri-Food biotech innovations for improved household nutritional security.

National Institute of Pharmaceutical Education & Research, Guwahati (NIPER-G) is an autonomous institute of National importance and the first national pharma institute in NE India set up by the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Govt. of India by an act ofparliament, to impart high-quality Education & Research in the area of Pharmaceutical Sciences. The Institute intents to fill the following Project position in DoP sponsored project through Online interview.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar. Innovation and speed form the crux of our business strategy.